Together, these data suggest EGFR as a potential therapeutic target for patients afflicted with neuropathic pain that in the treatment of cancer-related neuropathic pain may be at least partly distinct from the effect of EGFR therapies on the tumor itself. Here, EGFR is linked to neoplasm.